Iowa startups secured 13 federal awards totaling nearly $4 million in fiscal year 2022 through the SBIR/STTR outreach program administered by BioConnect Iowa.
Companies submitted a total of 38 applications for a 34 percent success rate, double the national average. The SBIR/STTR outreach program returned $7 in federal funds for every $1 in state funds invested.
Here’s a closer look at the Iowa startups receiving awards in FY 2022:
- NeoVaxSyn: $300,000 (NIH) for a nanovaccine for eliciting 10E8-bnAbs against HIV-1
- MTI Biotech: $256,000 (NIH) for 2-HOBA for treatment of pulmonary hypertension
- Frugi Biotechnology: $256,000 (NSF) for paper-based, secured diagnostics for managing viral outbreaks
- NanoSpy: $256,000 (NSF) for handheld graphene-based sensors for rapid detection of salmonella species in food-processing facilities
- Zymosense: $100,000 (NIST) for automated aqueous two-phase extraction for lost cost and scalable sorting of nanotubes
- Parametric Studio: $253,000 (NIH) for a virtual project-based learning sandbox for mimetics and medically inspired classroom engineering
- Zymosense: $256,000 (NSF) for a platform for rapid assessment of hydrolytic enzyme activity to optimize their design and use
- Juggernaut Life Sciences: $256,000 (NSF) for a smart semiautonomous fluid drainage system for surgical procedures
- Superior Statistical Research: $259,000 (NIH) for wastewater data integration and modeling to accurately predict community and organizational outbreaks due to viral pathogens
- Brainsoft: $256,000 (NSF) for using brainwaves in virtual reality applications
- Presaj: $256,000 (NSF) for combining machine learning with clinical expertise to assess and mitigate risk in healthcare
- pxAlpha: $300,000 (NIH) for a therapeutic medical device to reduce the risk of brachytherapy and increase adoption
- ETALYC: $963,000 (NSF) for information fusion-driven corridor-wide traffic signal re-timing (Phase II award)
To learn more about the SBIR/STTR program, click here.